IP Library Granted Patent US 11,707,584
Granted Patent B2
US 11,707,584 · App. 16/609,234 · Granted Jul 25, 2023

Inhaler flow control mechanism

Inventors: Peter D. Hodson (Derbyshire, GB); Stephen J. Howgill (Leicestershire, GB)
Assignee: Kindeva Drug Delivery L.P.
A61M15/0093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,584
App. No.
16/609,234
Granted
Jul 25, 2023
Kind
B2
Abstract

An inhaler ( 60 ) has a breath actuated trigger mechanism ( 100 ) reactive to an inhalation flow to trigger the release of a substance to be inhaled. The inhaler ( 60 ) has an inspiration flow which is subject to a higher degree of flow governing post-triggering than pre-triggering. This allows the triggering flow rate to be closer to, or even higher than, the governing flow rate of the inhaler.

Claims (21)

1. An inhaler comprising:

a breath actuated trigger mechanism reactive to an inhalation flow to trigger the release of a substance to be inhaled into the inhalation flow;

a first fluid flow path within the inhaler carrying part of the inhalation flow;

a flow governor arranged to govern inhalation flow through the first fluid flow path; and,

a second fluid flow path within the inhaler carrying part of the inhalation flow, the second fluid flow path bypassing the flow governor;

in which triggering the trigger mechanism reduces or blocks flow through the second fluid flow path,

in which the second flow path is at least partially blocked by a part of the trigger mechanism after triggering.

2. An inhaler according to claim 1 , in which the trigger mechanism comprises an actuation member configured to support a canister in a pre-triggered position, which actuation member moves to a post-triggered position upon triggering to thereby at least partially block the second flow path.

3. An inhaler according to claim 2 , in which the actuation member defines a valve member, and the inhaler comprises a valve seat for the second flow path, in which in the pre-triggered position of the actuation member the valve member and valve seat are spaced apart, and in the post-triggered position the valve member abuts the valve seat.

4. An inhaler according to claim 3 , in which the valve member and valve seat are shaped to mate upon engagement.

5. An inhaler according to claim 4 , in which the valve member is convex, and the valve seat is concave.

6. An inhaler according to claim 2 , in which the trigger mechanism comprises a toggle mechanism for selectively permitting movement of the actuation member from its pre-triggered position to its post-triggered position.

7. An inhaler according to claim 6 , in which the toggle mechanism comprises a vane positioned in the inhalation flow, the vane being moveable upon inhalation of a user to move the toggle mechanism between a primed condition in which the actuation member is maintained in its pre-triggered position by cooperation with the toggle mechanism and its post-triggered condition in which the toggle mechanism permits movement of the actuation member.

8. An inhaler according to claim 2 , in which the actuation member is an actuation arm that is pivotable about a pivot axis.

9. An inhaler according to claim 8 , in which the actuation arm is configured to at least partially block the second flow path at a position on the opposite side of the canister to the pivot axis.

10. An inhaler according to claim 1 , in which the first flow path has a first flow inlet defined on the inhaler, and the second flow path has a second flow inlet defined on the inhaler, distinct from the first.

11. An inhaler according to claim 10 , comprising a flow outlet for carrying an inhalation flow, in which the first and second flow inlets are adjacent the flow outlet.

12. An inhaler according to claim 10 , in which the first and second flow inlets are on opposites sides of the flow outlet.

13. An inhaler according to claim 11 , comprising a cover member configured to selectively cover the first and second flow inlets and the flow outlet.

14. An inhaler according to claim 1 , in which the trigger mechanism is positioned downstream of the second flow path.

15. An inhaler according to claim 14 , in which the trigger mechanism when it triggers reduces or blocks flow through the second fluid flow path upstream of a canister outlet.

Assignments (5)
SECURITY INTEREST Recorded Dec 14, 2022
From: KINDEVA DRUG DELIVERY L.P.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 062122/0618 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT R/F 053586/0715 Recorded Dec 12, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 062115/0707 →
SECURITY INTEREST Recorded Aug 24, 2020
From: KINDEVA DRUG DELIVERY L.P.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 053586/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2020
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: KINDEVA DRUG DELIVERY L.P.
Reel/Frame 052818/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2019
From: HODSON, PETER D.; HOWGILL, STEPHEN J.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 050848/0978 →
Priority Claims (1)
GB 1707095 · May 4, 2017 · national
Continuity (1)
Related Publication 20200069897A1 · Mar 5, 2020